October 23, 2002
The Hawaii State Department of Health Tuberculosis Control Program
has been awarded a ten-year contract by the U.S. Centers for Disease
Control and Prevention (CDC) to participate in the new TB Epidemiologic
Studies Consortium. Hawaii was one of only 22 sites selected for the
research program. Other partners include academic institutions and
state and county health departments from the U.S. and Canada.
The CDC contract amounts to $1.2 million over ten years for
Hawaii’s TB Program and will increase based on the research
projects conducted locally.
As a consortium member, Hawaii will be able to participate in
epidemiologic, behavioral, economic, laboratory, and operational
research on tuberculosis. Current research priorities for the
consortium include the following: TB among foreign-born persons, latent
TB infection, contact investigation, and new TB diagnostic tools. One
such diagnostic tool is the new Quaniferon test, a likely alternative
to traditional TB skin tests.
Dr. Jessie Wing, Chief of the Hawaii Tuberculosis Control Program,
is principle investigator for Hawaii. In addition, a new nurse
epidemiologist will be sought by the State to coordinate all subsequent
studies conducted locally.
According to Dr. Wing, "We are very fortunate to be part of this new
consortium where we will be able to participate in cutting edge
research. We believe that most epidemiologic research funded by the CDC
will be channeled through the consortium."
For further information, please contact the Tuberculosis Control
Program at 832-5731.
# # #